Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 3.7% year on year to $699.9 million. The company expects ...

As of Thursday, November 06, QuidelOrtho Corporation’s QDEL share price has dipped by 13.50%, which has investors questioning if this is right time to buy.

Get key Q3 2025 earnings insights for QuidelOrtho (QDEL): margin gains, core growth, narrowed guidance, and innovation focus.

Despite a 4% revenue drop, QuidelOrtho Corp (QDEL) focuses on organic growth and international market expansion to drive ...

The U.S. Food and Drug Administration ("FDA") has granted QuidelOrtho Corporation ("QuidelOrtho"), a global leader of in vitro diagnostics, 510(k) clearance for the VITROS hs Troponin I Reagent ...

If you're a frequent Panera Bread customer, you may soon see new drink options on the menu, but only in some cities. The restaurant chain announced on Oct. 15 it is testing two new "premium specialty" ...

The City Council approved legislation Thursday to ramp up testing requirements of building cooling towers for Legionnaires’ Disease, after an outbreak in Harlem over the summer sickened 114 people, ...

Criticism of animal research − usually associated with the progressive left − has grown in recent years, as the practice is blamed for the slow pace of drug development. The Food and Drug ...

(WJAR) — REGENT said its Seaglider prototype was damaged during an on-water hydrofoiling test on Saturday. According to officials, the Seaglider was returned to the testing facility after the damage.

Nearly four years after submitting a proposal to test-fire howitzers in the Adirondacks, Michael Hopmeier’s application to the Adirondack Park Agency is complete and out for public comment. The ...

Metro Transit on Tuesday will begin testing trains on the Metro Green Line Extension as construction on the project nears completion. The extension, also known as the southwest light rail project, ...

What Happened? Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 12.8% in the morning session after it reported disappointing third-quarter financial results and reduced its full ...